retatrutide fda approval 2026 just took a major step toward approval, and the numbers are unlike anything we've seen from a weight-loss injection. In Eli Lilly's phase 3 TRIUMPH-1 trial, participants on the highest When Will Retatrutide Be FDA
Description
We do not compound or dispense medications
Wegovy, Ozempic, Mounjaro, and Zepbound all use this route
)
As a macro coach, these numbers are all very familiar to me as I use some of these same metrics to calculate custom macro plans for my clients
The starting dose is 0.25 mg and is gradually increased every four weeks based on your bodys response
One reviewer noted mild nausea for the first week that resolved completely by week two
No Microdosing Studies Exist No study clinical trial, PK modeling, or case series has examined microdosing retatrutide
